- Home
- LE vs CDXS Comparison
LE vs CDXS Comparison
Compare LE & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LE
- CDXS
- Stock Information
- Founded
- LE 1963
- CDXS 2002
- Country
- LE United States
- CDXS United States
- Employees
- LE N/A
- CDXS N/A
- Industry
- LE Clothing/Shoe/Accessory Stores
- CDXS Major Chemicals
- Sector
- LE Consumer Discretionary
- CDXS Industrials
- Exchange
- LE Nasdaq
- CDXS Nasdaq
- Market Cap
- LE 280.4M
- CDXS 254.3M
- IPO Year
- LE N/A
- CDXS 2010
- Fundamental
- Price
- LE $12.89
- CDXS $3.11
- Analyst Decision
- LE Strong Buy
- CDXS Buy
- Analyst Count
- LE 1
- CDXS 2
- Target Price
- LE $20.00
- CDXS $11.00
- AVG Volume (30 Days)
- LE 462.0K
- CDXS 927.3K
- Earning Date
- LE 09-04-2025
- CDXS 08-07-2025
- Dividend Yield
- LE N/A
- CDXS N/A
- EPS Growth
- LE N/A
- CDXS N/A
- EPS
- LE 0.14
- CDXS N/A
- Revenue
- LE $1,338,672,000.00
- CDXS $49,815,000.00
- Revenue This Year
- LE $3.31
- CDXS $12.53
- Revenue Next Year
- LE $2.34
- CDXS $22.54
- P/E Ratio
- LE $94.79
- CDXS N/A
- Revenue Growth
- LE N/A
- CDXS N/A
- 52 Week Low
- LE $7.65
- CDXS $1.90
- 52 Week High
- LE $19.88
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- LE 68.75
- CDXS 59.74
- Support Level
- LE $12.50
- CDXS $2.77
- Resistance Level
- LE $13.60
- CDXS $3.39
- Average True Range (ATR)
- LE 0.71
- CDXS 0.20
- MACD
- LE 0.09
- CDXS 0.03
- Stochastic Oscillator
- LE 77.95
- CDXS 66.27
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.